相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
Amy Lightner et al.
JOURNAL OF CROHNS & COLITIS (2017)
Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab
Akihiro Yamada et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Impact of Preoperative Serum Anti-TNFα Therapy Levels on Early Postoperative Outcomes in Inflammatory Bowel Disease Surgery
Cheryl Lau et al.
ANNALS OF SURGERY (2015)
The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease
Geoffrey C. Nguyen et al.
JOURNAL OF CROHNS & COLITIS (2014)
Preoperative infliximab use and postoperative complications in Crohn's disease: A systematic review and meta-analysis
Zhi-Ping Yang et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Meta-analysis: peri-operative anti-TNF treatment and post-operative complications in patients with inflammatory bowel disease
N. Narula et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Tobacco Smoking and Postoperative Outcomes After Colorectal Surgery
Abhiram Sharma et al.
ANNALS OF SURGERY (2013)
Importance of Perioperative Glycemic Control in General Surgery A Report From the Surgical Care and Outcomes Assessment Program
Steve Kwon et al.
ANNALS OF SURGERY (2013)
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis
Vincent Billioud et al.
JOURNAL OF CROHNS & COLITIS (2013)
Financial Impact of Surgical Site Infections on Hospitals The Hospital Management Perspective
John Shepard et al.
JAMA SURGERY (2013)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
Laurent Peyrin-Biroulet et al.
GUT (2011)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
Certolizumab pegol for the treatment of Crohn's disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Maintenance therapy with certolizumab pegol for Crohn's disease
Stefan Schreiber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications
U Mahadevan et al.
INFLAMMATORY BOWEL DISEASES (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
分享论文
